Osaic Holdings
PDSB icon

Osaic Holdings’s PDS Biotechnology PDSB Stock Holding History

Osaic Holdings’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.4K Buy
+30,000
New +$31.8K ﹤0.01% 5949
2026
Q1 		– Sell
-17
Closed -$13 – 8006
2025
Q4 		$13 Hold
17
– – ﹤0.01% 7755
2025
Q3 		$17 Sell
17
-500
-97% -$588 ﹤0.01% 7840
2025
Q2 		$688 Buy
517
+17
+3% +$23 ﹤0.01% 7279
2025
Q1 		$595 Sell
500
-5,017
-91% -$7.14K ﹤0.01% 6956
2024
Q4 		$8.99K Buy
5,517
+250
+5% +$662 ﹤0.01% 5864
2024
Q3 		$20.1K Hold
5,267
– – ﹤0.01% 5380
2024
Q2 		$15.4K Buy
5,267
+17
+0.3% +$54 ﹤0.01% 5518
2024
Q1 		$20.8K Buy
5,250
+5,000
+2,000% +$25.8K ﹤0.01% 5343
2023
Q4 		$1.24K Sell
250
-6,000
-96% -$29.8K ﹤0.01% 6676
2023
Q3 		$31.6K Buy
6,250
+4,250
+213% +$23.3K ﹤0.01% 5289
2023
Q2 		$10.1K Sell
2,000
-500
-20% -$3.27K ﹤0.01% 5957
2023
Q1 		$15.4K Buy
2,500
+1,498
+150% +$12.3K ﹤0.01% 5722
2022
Q4 		$13K Buy
1,002
+2
+0.2% +$14 ﹤0.01% 5817
2022
Q3 		$3K Sell
1,000
-11
-1% -$47 ﹤0.01% 6650
2022
Q2 		$4K Sell
1,011
-120
-11% -$571 ﹤0.01% 6614
2022
Q1 		$7K Sell
1,131
-250
-18% -$1.55K ﹤0.01% 6338
2021
Q4 		$11K Sell
1,381
-250
-15% -$2.69K ﹤0.01% 6190
2021
Q3 		$25K Sell
1,631
-880
-35% -$11K ﹤0.01% 5618
2021
Q2 		$32K Buy
2,511
+1,000
+66% +$7.81K ﹤0.01% 5370
2021
Q1 		$7K Buy
1,511
+700
+86% +$2.82K ﹤0.01% 6035
2020
Q4 		$2K Hold
811
– – ﹤0.01% 6089
2020
Q3 		$2K Buy
811
+800
+7,273% +$2.24K ﹤0.01% 5882
2020
Q2 		$0 Hold
11
– – ﹤0.01% 6272
2020
Q1 		$0 Buy
+11
New +$19 ﹤0.01% 6149

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Osaic Holdings's PDSB Position: Q2 2026 in Review

Osaic Holdings opened a new position in PDS Biotechnology (PDSB) in Q2 2026: 30,000 shares worth $26.4K. The stake represents ﹤0.01% of the portfolio and ranks #5949 among its holdings. This is a return to the name: Osaic Holdings previously reported a position in PDSB as recently as Q4 2025.

Osaic Holdings first reported a position in PDSB in Q1 2020 and has held it in 25 quarters since. The position peaked at $32K in Q2 2021. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • Osaic Holdings held 30,000 shares of PDS Biotechnology worth $26.4K as of Q2 2026.
  • PDS Biotechnology was a new Osaic Holdings position in Q2 2026.
  • PDS Biotechnology made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5949 holding.
  • Osaic Holdings first reported a position in PDS Biotechnology in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's PDS Biotechnology position peaked at $32K in Q2 2021.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.